FTO and acute myeloid leukemia: In acute myeloid leukemia (AML), mimicking FTO depletion, an FTO inhibitor FB23-2 significantly inhibited the proliferation of human AML cell lines and primary cells in vitro and promoted cell differentiation/apoptosis (11).